BURDEN OF ILLNESS AMONG PATIENTS WITH HEREDITARY TRANSTHYRETIN (HATTR) AMYLOIDOSIS

被引：0
|
作者：
Reddy, S. R. [1 ]
Guthrie, S. [2 ]
Chang, E. [1 ]
Tieu, R. S. [1 ]
Tarbox, M. [1 ]
Pollock, M. [3 ]
机构：
[1] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[2] Biopharma Strateg Consulting LLC, San Francisco, CA USA
[3] Akcea Therapeut, Carlsbad, CA USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO43
引用
收藏
页码：S848 / S848
页数：1
相关论文
共 50 条
  • [21] Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
    Daniel P. Judge
    Arnt V. Kristen
    Martha Grogan
    Mathew S. Maurer
    Rodney H. Falk
    Mazen Hanna
    Julian Gillmore
    Pushkal Garg
    Akshay K. Vaishnaw
    Jamie Harrop
    Christine Powell
    Verena Karsten
    Xiaoping Zhang
    Marianne T. Sweetser
    John Vest
    Philip N. Hawkins
    Cardiovascular Drugs and Therapy, 2020, 34 : 357 - 370
  • [22] Impact of baseline neuropathy stage in patients with hereditary transthyretin-mediated (hATTR) amyloidosis with or without patisiran treatment
    Kyriakides, T.
    Brannagan, T.
    Lin, H.
    Wang, Y.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 190 - 190
  • [23] Neurofilament Light Chain (NfL) as a Potential Biomarker in Hereditary Transthyretin-Mediated (hATTR) Amyloidosis
    Nioi, Paul
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Chan, Amy
    Gilbert, Jason
    Erbe, David
    Fitzgerald, Kevin
    NEUROLOGY, 2020, 94 (15)
  • [24] Indirect comparison of patisiran and tafamidis for treatment of hereditary transthyretin- mediated (hATTR) amyloidosis with polyneuropathy
    Coelho, Teresa
    Polydefkis, Michael
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Plante-Bordeneuve, Violaine
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 254 - 255
  • [25] Neurofilament light chain (NfL) as a potential biomarker in hereditary transthyretin-mediated (hATTR) amyloidosis
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Vaishnaw, Akshay
    Nioi, Paul
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S13 - S13
  • [26] Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
    Luigetti, Marco
    Romano, Angela
    Di Paolantonio, Andrea
    Bisogni, Giulia
    Sabatelli, Mario
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2020, 16 : 109 - 123
  • [27] Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
    Daniel P. Judge
    Arnt V. Kristen
    Martha Grogan
    Mathew S. Maurer
    Rodney H. Falk
    Mazen Hanna
    Julian Gillmore
    Pushkal Garg
    Akshay K. Vaishnaw
    Jamie Harrop
    Christine Powell
    Verena Karsten
    Xiaoping Zhang
    Marianne T. Sweetser
    John Vest
    Philip N. Hawkins
    Cardiovascular Drugs and Therapy, 2020, 34 : 889 - 889
  • [28] THE BURDEN OF HEREDITARY TRANSTHYRETIN AMYLOIDOSIS ON HEALTH RELATED QUALITY OF LIFE
    Lovley, A.
    Guthrie, S. D.
    Kessler, Sikora A.
    Yarlas, A.
    Pollock, M. R.
    Patel, P.
    White, M. K.
    VALUE IN HEALTH, 2018, 21 : S257 - S257
  • [29] Cardiovascular Disease Burden Prior To Hereditary Transthyretin Amyloidosis Diagnosis
    Llonch, Montserrat V.
    Ortiz-Perez, Jose T.
    Reddy, Sheila R.
    Chang, Eunice
    Tarbox, Marian H.
    Pollock, Michael R.
    Nativi-Nicolau, Jose
    Fine, Nowell M.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S125 - S126
  • [30] Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data
    Brandman, Danielle
    Lin, Hollis
    McManus, Anastasia
    Agarwal, Sonalee
    Gache, Larry M.
    Irish, William
    Gollob, Jared
    Zivkovic, Sasa A.
    PROGRESS IN TRANSPLANTATION, 2019, 29 (03) : 213 - 219
12345